Hôpital Erasme
Hospital
Location:
Brussels,
Belgium (BE)
ISNI: 000000008571829X
ROR: https://ror.org/05j1gs298
Show on Map:
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018)
Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al.
Journal article
nutritionDay: 10 years of growth (2017)
Schindler K, Pichard C, Sulz I, Volkert D, Streicher M, Singer P, Ljungqvist E, et al.
Journal article
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017)
Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al.
Journal article